Trevi Therapeutics, Inc.TRVINASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank11
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-44.57M
↓ 62% vs avg
Percentile
P11
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-27.57M
Historical baseline
PeriodValueYoY Change
TTM$-44.57M+6.7%
2024$-47.79M-67.2%
2023$-28.58M-2.1%
2022$-27.98M+14.5%
2021$-32.71M-1.4%
2020$-32.27M-21.3%
2019$-26.61M-44.7%
2018$-18.39M-124.5%
2017$-8.19M+5.0%
2016$-8.62M-